IRC begins RLT ‘Full Protocol’ treatment option to study Alopecia Areata response
Chicago, IL – Immune Research Center’s Healing Alopecia Areata Program recently announced that it has begun to selectively offer its RLT “Full Protocol” treatment option to study the response of Alopecia Areata, Totalis, and Universalis patients.
The RLT ‘full protocol’ is a medically-supervised, combination therapy intended to restore intestinal homeostasis, support epithelial cell recovery and function, curb systemic inflammation, and promote superior metabolic/cellular health to reverse autoimmune Alopecia Areata expression and possibly comorbid conditions.
Their Healing Alopecia Areata program (HAA) currently offers RLT Microbiotic Dietary therapy, which incorporates components of the ‘full protocol’ in the form of strict and targeted dietary guidelines and nutritional supplementation. According to HAA, this less-potent portion of the RLT intervention strategy is a recommended first step prior to considering the full protocol intervention.
The decision to initiate full protocol study builds on positive experience data that the HAA program continues to gain while working with self-reporting patients employing its RLT-Prommune nutritional therapy.
IRC encourages medical researchers and practitioners specializing in the study and/or treatment of Alopecia Areata to inquire about RLT. Interested parties can email email@example.com for more information.